Compared to ER COVID-PF, controls, and IPF, LR COVID-PF had fewer naïve CD4+ T cells, and their CD8+ T cells expressed significantly greater levels of activation markers (HLA-DR and CD38). This evidence concerns the gene CD4 and idiopathic pulmonary fibrosis.